Bausch Health: A Deep-Value Bet Amidst Patent Woes and Hidden Assets
Despite a sharp sell-off following a key clinical trial setback, Bausch Health's significant stake in Bausch + Lomb and pipeline catalysts present a potential opportunity for patient value investors.